002898 赛隆药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.3031.795-6.846-4.057-10.790
总资产报酬率 ROA (%)0.2031.147-4.312-2.751-8.148
投入资产回报率 ROIC (%)0.2311.351-5.131-3.171-9.359

边际利润分析
销售毛利率 (%)39.73646.18653.46666.22064.115
营业利润率 (%)3.1337.265-10.897-5.498-38.934
息税前利润/营业总收入 (%)5.1789.361-8.621-3.403-36.139
净利润/营业总收入 (%)2.3373.069-14.123-9.447-55.701

收益指标分析
经营活动净收益/利润总额(%)148.701-11.329123.789182.717166.365
价值变动净收益/利润总额(%)3.10035.401-57.609-110.568-68.777
营业外收支净额/利润总额(%)-1.874-0.9402.9681.3363.766

偿债能力分析
流动比率 (X)1.1541.1290.8581.0851.277
速动比率 (X)0.7590.7380.6420.8860.947
资产负债率 (%)31.46734.15437.93236.15027.883
带息债务/全部投入资本 (%)19.35320.60323.48823.661--
股东权益/带息债务 (%)399.084367.609318.544317.209466.953
股东权益/负债合计 (%)217.788192.790163.631176.628258.640
利息保障倍数 (X)2.4634.326-3.304-1.568-8.369

营运能力分析
应收账款周转天数 (天)49.49151.81281.61976.3280.000
存货周转天数 (天)180.652164.582171.230249.5580.000